Oct 2026· Annals of Surgical Oncology· 0 citations· 23 references
Medicine
TL;DR
Those with poor baseline financial health or disrupted employment were most vulnerable and may benefit from early financial counseling and support interventions.
Abstract
Background
Esophagectomy for esophageal cancer is associated with significant morbidity and can result in financial hardship, yet this aspect of survivorship remains understudied. This study evaluated the prevalence and risk factors of financial toxicity (FT) among patients following esophagectomy.
Methods
Patients who underwent esophagectomy between January 2016 and September 2022 were surveyed about demographic, financial, and employment history. Financial toxicity was measured by using the validated COST survey. Multivariate analyses identified predictors of FT.
Results
Of 370 patients contacted, 159 (43%) completed the survey. Median age was 65.3 years; 82.4% were male. Following therapy, 44.7% reported decreased work hours or stopped working entirely. Insurance was employer-based for 50.3%, while 40.6% had Medicare. Financial toxicity was reported by 37.1%. Risk factors included larger household size (odds ratio 2.3), low credit score (odds ratio 13.2), while high income and active retirement were protective.
Conclusions
More than a third of esophagectomy patients were found to have FT. Those with poor baseline financial health or disrupted employment were most vulnerable and may benefit from early financial counseling and support interventions.
ABSTRACT Background Financial toxicity threatens the survival and prognosis of cervical cancer patients, yet systematic exploration of its prevalence and full spectrum of protective and risk factors remains limited. Aims To investigate the prevalence and factors associated with financial toxicity among patients with ce...
BACKGROUND
Nearly 40% of new cases of esophageal cancer are diagnosed at stage 4. Esophagectomy may offer a survival benefit in highly selected patients with stage 4 esophageal cancer.
METHODS
A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines. Databases including PubMed, Embase...
Nian-Ye Zheng, David B. Sewell, Si-Qi Chen et al.· Annals of Thoracic Surgery· 0 citations
241
Background:
Financial toxicity (FT) has now been established as a treatment-related harm in oncology, including among patients with breast cancer. However, the evidence base rests largely on data from the United States, where patient cost-sharing is substantial. Few studies have characterized FT in high-inc...
R. Sabelli, Sarah Mashal, Lianne Simon et al.· JCO Oncology Practice· 0 citations
ABSTRACT Background Financial toxicity (FT) describes the impact of cancer and treatment‐related financial burden. We evaluated the prevalence and risk factors for FT among sarcoma patients. Methods A sarcoma cohort was constructed to assess health outcomes. FT was measured via “COmprehensive Score for financial Toxici...
Michael J. Robinson, Li-Li Sun, Tatsuki Koyama et al.· Cancer Reports· 0 citations
BACKGROUND
The prognosis of esophageal and gastric carcinoma in situ (CIS) is excellent but population-level incidence pattern and mortality determinants remain limited.
METHODS
We conducted a nationwide study using Korea Healthcare Bigdata. National Cancer Registry data were linked with Health Insurance Review and A...
S. Nam, Junwoo Jo, Sung Kook Kim· Digestion· 0 citations
BACKGROUND
Gallbladder cancer (GBC) is a rare but aggressive malignancy with poor long-term survival after resection. National data describing temporal changes in adjuvant therapy, surgical quality metrics, and facility-level outcomes remain limited.
METHODS
A retrospective cohort study was performed using the Nation...
R. Cardoso, E. Zineldin, Y. Sakr et al.· Journal of Surgical Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.